Navacaprant did not statistically significantly improve MADRS total score or SHAPS total score compared with placebo. Topline data were announced from a phase 3 trial evaluating navacaprant for the ...
News-Medical.Net on MSN
Short-duration psychedelic therapy shows promise for major depression treatment
By Tarun Sai Lomte A controlled clinical trial suggests a fast-acting psychedelic approach may reduce depressive symptoms, but researchers stress careful interpretation and the need for larger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results